SciTransfer
Expertise area

Biomedical and health research

5 European H2020 organizations list this as part of their work1 as their primary capability.

Top organizations

Most active in this area

  • UNIVERSITETET I BERGEN

    Major Norwegian research university leading in climate modelling, marine science, and European research data infrastructure across 170 H2020 projects.

    Contributes to clinical and translational health projects including ALEC (lung disease cohorts), CoCA (ADHD comorbidities), AML-VACCiN (leukaemia immunotherapy), ULTRADIAN (hormone diagnostics), and SELFIE (integrated care models).

    NO170 projects
  • UNIVERSITAET INNSBRUCK

    Austrian research university with top-tier quantum physics, digital humanities, and growing strength in AI, climate science, and health research.

    Projects span cancer diagnostics (SNIFFPHONE for breath-based gastric cancer detection), immune aging (ImmunoAgeing), drug discovery (HALODRUGSYN), and healthy aging (MediHealth).

    AT103 projects
  • UNIVERSITA DEGLI STUDI DI PERUGIA

    Broad Italian research university strong in food authenticity, energy systems, biomedical research, and large-scale science engagement across 55 partner countries.

    Largest single grant (ContraNPM1AML, EUR 1.88M) on acute myeloid leukemia therapeutics, plus Sjögren Syndrome data integration (HarmonicSS) and diabetes cell therapy (ELASTISLET).

    IT69 projects
  • UNIVERSIDAD DE MURCIA

    Spanish university combining cybersecurity, IoT, and 5G trust research with applied expertise in smart agriculture and aquaculture sustainability.

    Coordinated REP-BIOTECH (reproductive health doctorate) and OpMaEye (macular pigment optical device), participated in PRECISE4Q (stroke predictive modeling) and contributed to DIABFRAIL-LATAM.

    ES44 projects
  • MONASH UNIVERSITY

    Australia's leading H2020 partner university, contributing specialist research across health, materials science, astrophysics, and researcher mobility programmes.

    Projects spanning autoimmune disease (RELENT), prostate cancer plasticity (PDX-PC), gestational diabetes prevention (IMPACT DIABETES B2B), digital health tools (DigiCare4You), and preterm birth outcomes (TVPIPD).

    PrimaryAU22 projects